SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-24-000021
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:32
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20240930.htm   iXBRL 10-Q 758602
2 EX-31.1 sls-20240930ex311.htm EX-31.1 8221
3 EX-31.2 sls-20240930ex312.htm EX-31.2 8208
4 EX-32.1 sls-20240930ex321.htm EX-32.1 6587
5 EX-32.2 sls-20240930ex322.htm EX-32.2 6577
11 sls-20240930_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-24-000021.txt   4723577

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20240930.xsd EX-101.SCH 36653
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20240930_cal.xml EX-101.CAL 43059
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20240930_def.xml EX-101.DEF 147522
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20240930_lab.xml EX-101.LAB 494458
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20240930_pre.xml EX-101.PRE 336630
66 EXTRACTED XBRL INSTANCE DOCUMENT sls-20240930_htm.xml XML 560567
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 241453865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)